Ashley McEvoy
CIK 1745936 · President and CEO · last filed 2026-10-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
JNJ price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ONE PROCTER & GAMBLE PLAZA
CINCINNATI, OH 45202
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PG | Director | 7,666 | $161.02 | $1.23M | $0 | 15 | 2026-10-14 |
| PODD | President and CEO | 23,735 | $149.01 | $3.54M | $1.19M | 5 | 2026-08-24 |
| JOHNSON & JOHNSON (JNJ.WD) Delisted | EVP, WW Chair, MedTech | 52,337 | — | — | $0 | 1 | 2023-08-25 |
| JNJ | EVP, WW Chair, MedTech | 62,282 | $263.81 | $16.43M | -$17.14M | 13 | 2023-02-15 |
Recent Filings · Page 2 of 4
36 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-10 | PG | Grant (A) | +189 | $0 | EDGAR |
| 2025-06-11 | PG | Grant (A) | +185 | $0 | EDGAR |
| 2025-05-15 | PODD | Grant (A) | +9,540 | $0 | EDGAR |
| 2025-03-12 | PG | Grant (A) | +145 | $0 | EDGAR |
| 2024-12-11 | PG | Grant (A) | +175 | $0 | EDGAR |
| 2024-10-09 | PG | Grant (A) | +1,309 | $0 | EDGAR |
| 2024-09-11 | PG | Grant (A) | +169 | $0 | EDGAR |
| 2024-06-12 | PG | Grant (A) | +180 | $0 | EDGAR |
| 2024-03-13 | PG | Grant (A) | +155 | $0 | EDGAR |
| 2024-02-09 | JNJ | Notice (144) | −24,613 | -$3.85M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.